Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Time to think outside the (genetic) box.

Issa JP, Garber JE.

Cancer Prev Res (Phila). 2011 Jan;4(1):6-8. doi: 10.1158/1940-6207.CAPR-10-0348.

2.

[Clinical and molecular diagnosis of inherited breast-ovarian cancer].

Chompret A.

J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. Review. French.

3.

Counseling the at risk patient in the BRCA1 and BRCA2 Era.

Barnes-Kedar IM, Plon SE.

Obstet Gynecol Clin North Am. 2002 Jun;29(2):341-66, vii. Review.

PMID:
12108833
4.

The prevention of hereditary breast cancer.

Rodriquez E, Domchek SM.

Semin Oncol. 2007 Oct;34(5):401-5. Review.

PMID:
17920894
5.

Breast cancer genetics in African Americans.

Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C.

Cancer. 2003 Jan 1;97(1 Suppl):236-45. Review.

6.

Clinical practice. Management of an inherited predisposition to breast cancer.

Robson M, Offit K.

N Engl J Med. 2007 Jul 12;357(2):154-62. Review. No abstract available.

PMID:
17625127
7.

Pitfalls and caveats in BRCA sequencing.

Bellosillo B, Tusquets I.

Ultrastruct Pathol. 2006 May-Jun;30(3):229-35. Review.

PMID:
16825125
8.

Inherited predisposition and breast cancer: modifiers of BRCA1/2-associated breast cancer risk.

Rebbeck TR.

Environ Mol Mutagen. 2002;39(2-3):228-34. Review.

PMID:
11921193
10.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
11.

18. Genetics of breast cancer.

Irving M, Elmslie F, Berg J.

Int J Clin Pract. 2002 Nov;56(9):677-82. Review.

PMID:
12469982
12.

[Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?].

Bonadona V, Lasset C.

Bull Cancer. 2003 Jul;90(7):587-94. Review. French.

13.

Identifying and managing hereditary risk of breast and ovarian cancer.

Frank TS, Critchfield GC.

Clin Perinatol. 2001 Jun;28(2):395-406. Review.

PMID:
11499060
14.

[BRCA1 and BRCA2: mutations and other genetic changes--practical relevance].

Scherneck S, Hofmann W.

Chirurg. 1999 Apr;70(4):373-9. Review. German.

PMID:
10354832
15.

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Nelson HD, Huffman LH, Fu R, Harris EL; U.S. Preventive Services Task Force..

Ann Intern Med. 2005 Sep 6;143(5):362-79. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547.

PMID:
16144895
16.

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.

Fackenthal JD, Olopade OI.

Nat Rev Cancer. 2007 Dec;7(12):937-48. Review.

PMID:
18034184
17.

BRCA1, BRCA2 and breast cancer: a concise clinical review.

Carter RF.

Clin Invest Med. 2001 Jun;24(3):147-57. Review.

PMID:
11437066
18.

BRCA2: a genetic risk factor for breast cancer.

Schwab M, Claas A, Savelyeva L.

Cancer Lett. 2002 Jan 10;175(1):1-8. Review.

PMID:
11734330
19.

A review of hereditary breast cancer: from screening to risk factor modification.

Warmuth MA, Sutton LM, Winer EP.

Am J Med. 1997 Apr;102(4):407-15. Review.

PMID:
9217624
20.

One-hit effects and cancer.

Iniesta MD, Chien J, Wicha M, Merajver SD.

Cancer Prev Res (Phila). 2010 Jan;3(1):12-5. doi: 10.1158/1940-6207.CAPR-09-0249. Review.

Supplemental Content

Support Center